Efficacy and Safety of Dual Therapy for Helicobacter Pylori Eradication

PHASE4CompletedINTERVENTIONAL
Enrollment

914

Participants

Timeline

Start Date

August 1, 2022

Primary Completion Date

August 31, 2023

Study Completion Date

September 30, 2023

Conditions
Helicobacter Pylori Infection
Interventions
DRUG

Vonoprazan

Potassium-competitive acid blocker

DRUG

Amoxicillin

Antibiotic for H. pylori eradication

Trial Locations (10)

Unknown

Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing

Nanjing First Hospital, Nanjing Medical University, Nanjing

Changshu No.1 People's Hospital, Suzhou

Second Affiliated Hospital of Soochow University, Suzhou

Taixing People's Hospital, Taizhou

Taizhou Fourth People's Hospital, Taizhou

Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi

The First People's Hospital of Xuzhou, Xuzhou Municipal Hospital Affiliated to Xuzhou Medical University, Xuzhou

Yancheng First Hospital,Affiliated Hospital of Nanjing University Medical School, Yancheng

Affiliated Hospital of Yangzhou University, Yangzhou

All Listed Sponsors
lead

Nanjing First Hospital, Nanjing Medical University

OTHER